OncoImmunology
Volume 10, 2021 - Issue 1
Original Research
Impact of IL-1β and the IL-1R antagonist on relapse risk and survival in AML patients undergoing immunotherapy for remission maintenance
Hanna Grauers Wiktorina TIMM Laboratory, Sahlgrenska Center for Cancer Research, Department of Infectious Diseases, Institute of Biomedicine, Sahlgrenska Academy, University of Gothenburg, Sweden
https://orcid.org/0000-0002-4412-5695View further author information
https://orcid.org/0000-0002-4412-5695View further author information, Ebru Aydina TIMM Laboratory, Sahlgrenska Center for Cancer Research, Department of Infectious Diseases, Institute of Biomedicine, Sahlgrenska Academy, University of Gothenburg, Sweden;b Molecular Genetics, Germany Cancer Research Center (DKFZ), Heidelberg, Germanyhttps://orcid.org/0000-0003-2395-7529View further author information
https://orcid.org/0000-0003-2395-7529View further author information, Karin Christensona TIMM Laboratory, Sahlgrenska Center for Cancer Research, Department of Infectious Diseases, Institute of Biomedicine, Sahlgrenska Academy, University of Gothenburg, Sweden;c Department of Oral Microbiology and Immunology, Institute of Odontology, Sahlgrenska Academy, University of Gothenburg, Swedenhttps://orcid.org/0000-0003-2489-2253View further author information
https://orcid.org/0000-0003-2489-2253View further author information, Nuttida Issdisaia TIMM Laboratory, Sahlgrenska Center for Cancer Research, Department of Infectious Diseases, Institute of Biomedicine, Sahlgrenska Academy, University of Gothenburg, Swedenhttps://orcid.org/0000-0002-5103-6148View further author information
https://orcid.org/0000-0002-5103-6148View further author information, Fredrik B. Thorénd TIMM Laboratory, Sahlgrenska Center for Cancer Research, Department of Medical Biochemistry and Cell Biology, Institute of Biomedicine, Sahlgrenska Academy, University of Gothenburg, Swedenhttps://orcid.org/0000-0003-2167-7451View further author information
https://orcid.org/0000-0003-2167-7451View further author information, Kristoffer Hellstranda TIMM Laboratory, Sahlgrenska Center for Cancer Research, Department of Infectious Diseases, Institute of Biomedicine, Sahlgrenska Academy, University of Gothenburg, Swedenhttps://orcid.org/0000-0002-6617-5976View further author information
https://orcid.org/0000-0002-6617-5976View further author information & Anna Martnera TIMM Laboratory, Sahlgrenska Center for Cancer Research, Department of Infectious Diseases, Institute of Biomedicine, Sahlgrenska Academy, University of Gothenburg, SwedenCorrespondence[email protected]
https://orcid.org/0000-0002-6598-5221View further author information
https://orcid.org/0000-0002-6598-5221View further author information show all